Internal Medicine · South Burlington, VT
NPI
1285682666
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
368 Dorset St, Suite 1
South Burlington, VT, 05403
Phone (802) 860-1441
Groups this clinician bills Medicare through
Medicare paid, 2024
$11K
1,234 services
Medicare patients, 2024
255
Average age 76
Drug cost, 2024
$1.8M
16,293 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark Pitcher was code 85027 (blood count), 173 times for 156 patients. In total Mark Pitcher billed 1,234 services in 28 codes, and Medicare paid $11K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 85027 Blood Count | Office | 173 | 156 | $6.31 | $1,091 |
| 80053 Clinical Chemistry | Office | 171 | 165 | $10.30 | $1,761 |
| 80061 Clinical Chemistry | Office | 158 | 151 | $13.05 | $2,062 |
| 83036 Blood Count | Office | 130 | 79 | $9.46 | $1,230 |
| 84443 Clinical Chemistry | Office | 66 | 61 | $16.46 | $1,086 |
| 80048 Clinical Chemistry | Office | 52 | 46 | $8.29 | $431 |
| G0103 Prostate cancer screening; prostate specific antigen test (psa) | Office | 35 | 35 | $18.92 | $662 |
| 84153 Clinical Chemistry | Office | 27 | 26 | $17.46 | $471 |
| 93000 Electrocardiogram | Office | 14 | 14 | $10.12 | $142 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 11 | 11 | $37.35 | $411 |
By year: 2022 $12K for 1,152 services; 2023 $13K for 1,142 services; 2024 $11K for 1,234 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85027 Blood Count | 173 | 156 | $6.31 | $1,091 |
| 80053 Clinical Chemistry | 171 | 165 | $10.30 | $1,761 |
| 80061 Clinical Chemistry | 158 | 151 | $13.05 | $2,062 |
| 83036 Blood Count | 130 | 79 | $9.46 | $1,230 |
| 84443 Clinical Chemistry | 66 | 61 | $16.46 | $1,086 |
| 80048 Clinical Chemistry | 52 | 46 | $8.29 | $431 |
| G0103 Prostate cancer screening; prostate specific antigen test (psa) | 35 | 35 | $18.92 | $662 |
| 84153 Clinical Chemistry | 27 | 26 | $17.46 | $471 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark Pitcher prescribed most often to Medicare patients was Atorvastatin Calcium, with 949 prescriptions and refills. In total Mark Pitcher wrote 16,293 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 949 | 1,917 | 194 | $12K |
| Levothyroxine Sodium Generic | 482 | 939 | 100 | $5,796 |
| Tamsulosin Hcl Generic | 477 | 858 | 90 | $9,368 |
| Lisinopril Generic | 474 | 963 | 101 | $3,943 |
| Eliquis Apixaban | 419 | 637 | 70 | $289K |
| Losartan Potassium Generic | 387 | 935 | 94 | $4,473 |
| Gabapentin Generic | 380 | 520 | 65 | $6,656 |
| Omeprazole Generic | 374 | 764 | 89 | $6,393 |
| Amlodipine Besylate Generic | 371 | 765 | 85 | $2,934 |
| Sertraline Hcl Generic | 356 | 518 | 55 | $2,986 |
| Metoprolol Succinate Generic | 316 | 508 | 60 | $4,484 |
| Pantoprazole Sodium Generic | 288 | 483 | 68 | $3,754 |
| Rosuvastatin Calcium Generic | 273 | 659 | 68 | $6,622 |
| Quetiapine Fumarate Generic | 250 | 258 | 19 | $2,889 |
| Metoprolol Tartrate Generic | 232 | 370 | 39 | $2,007 |
Brand drugs: 2,168 claims; generic drugs: 14,042 claims; opioid claims: 619.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Mark Pitcher were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.